← Evidence map

ArticleTherapeutic advances in neurological disorders2025

Switch from fingolimod to ozanimod for safety or intolerance reasons.

Elisabetta Signoriello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40655996